Product Information

HALOBETASOL PROP 0.05% OINTMNT is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.7781 per GM under NDC 45802013135. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Dec 16, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

HALOBETASOL PROP 0.05% OINTMNT

Halobetasol Propionate
$0.7781per GM

Strength

.5 mg/g

NDC

45802013135

Classification

Generic

Dosage Form

OINTMENT

Route

TOPICAL

Effective Date

11/18/2026

Active Ingredients

HALOBETASOL PROPIONATE

Approval Type

Generic (ANDA)

FDA Application

ANDA076872

FDA Approved

12/16/2004

TE Code

AB

On Market Since

2/5/2009

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for HALOBETASOL PROP 0.05% OINTMNT has been published 678 times since Nov 28, 2013, and over the history we have for it it has declined 79.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7781 per GM
All-time high$4.2931 (Feb 11, 2015)
All-time low$0.6610 (Jun 17, 2026)
52-week high$0.8428
52-week low$0.6610
Median price$2.4842
Average price$2.3851
Largest weekly change+60.8% (Nov 23, 2022)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

-2.0%

1M

-7.7%

3M

-7.3%

6M

+9.4%

1Y

-0.9%

3Y

-31.2%

5Y

-63.0%

All

-79.5%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 43% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 43%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of HALOBETASOL PROP 0.05% OINTMNT?

The current National Average Drug Acquisition Cost (NADAC) for HALOBETASOL PROP 0.05% OINTMNT, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.7781 per GM (NDC 45802013135), effective Nov 18, 2026.

How has the price of HALOBETASOL PROP 0.05% OINTMNT changed over time?

Over the history we have for it, the NADAC for HALOBETASOL PROP 0.05% OINTMNT has declined 79.5%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for HALOBETASOL PROP 0.05% OINTMNT?

Since Nov 28, 2013, the NADAC for HALOBETASOL PROP 0.05% OINTMNT has ranged from a low of $0.6610 (Jun 17, 2026) to a high of $4.2931 (Feb 11, 2015), with a median of $2.4842 per GM.

Are there cheaper alternatives to HALOBETASOL PROP 0.05% OINTMNT?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HALOBETASOL PROP 0.05% OINTMNT, is $0.4446 per GM — about 43% below HALOBETASOL PROP 0.05% OINTMNT.

Who manufactures HALOBETASOL PROP 0.05% OINTMNT?

HALOBETASOL PROP 0.05% OINTMNT (NDC 45802013135) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.